Published estimates of liver fibrosis progression in individuals with chronic hepatitis C virus
(HCV) infection are heterogeneous. We aimed to estimate stage‐specific fibrosis …

Hepatitis C virus (HCV) infection is highly prevalent among chronic kidney disease (CKD)
subjects under hemodialysis and in kidney transplantation (KT) recipients, being an …

The aim of our study was to assess hepatitis C virus (HCV) evolution and long-term liver
histology outcome in anti-HCV (+)/RNA (+) renal transplant (RT) patients. A total of 51 anti …

Background Kidney transplantation (KTx) alone in patients with cirrhosis and renal failure
(end-stage renal disease [ESRD]) infected with hepatitis C virus (HCV) is controversial. The …

Background & Aims: Liver biopsy is useful for staging fibrosis in chronic hepatitis C (CHC)
patients with end-stage renal disease (ESRD) to determine renal transplant eligibility and to …

The management of hepatitis C virus (HCV)-infected patients with chronic kidney disease
(CKD) is complex and represents a particular concern since numerous issues, such as …

The prevalences of chronic infection by hepatitis C virus (HCV) and its genotypes vary
among countries and ethnic groups. Among patients with end-stage renal disease (ESRD) …

An investigation was conducted involving 255 renal transplant recipients in the state of
Goiás, Central Brazil, to determine the prevalence of hepatitis C virus (HCV), its risk factors …

Introduction: Renal transplant (RTx) patients with hepatitis C frequently show normal levels
of alanine aminotransferase (ALT) and the significance of ALT in this group has not been …

The aim of our study was to assess the long-term liver histology in renal transplant patients
infected with hepatitis C virus (HCV) who were treated with a cyclosporine-based regimen …